Infusion Rate of Rocuronium for Deep Neuromuscular Blockade

Not Applicable

Recruiting

• Conditions: Elective surgical patients

• Registration Number: JPRN-UMIN000022599
• Lead Sponsor: Jikei University School of Medicine, Department of Anesthesiology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-03
• Last Update Posted: 17 October 2023
• Study Completion: 2027-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Not provided

Exclusion Criteria

1. American Society of Anesthesiologists criteria; 3 or more. 2. Pregnant patients. 3. Body mass index; 30 kg/m2 or more. 4. Body mass index; less than 18.5 kg/m2. 5. Severe renal dysfunction patients; serum creatinine exceeded reference value. 6. Hepatic dysfunction patients; serum transaminase more than 100 U/L. 7. Patients with metabolic disorder. 8. Patients with neuromuscular disorder. 9. Patients with dyspnea, airway stenosis, and/or bronchial asthma. 10. Patients with hypersensitivity for rocuronium or sugammadex. 11. Patients with atopic disease. 12. Patients with systemic allergic symptoms. 13. Taking antihistamine and/or antiallergic drugs for more than a month. 14. Taking calcium antagonists, anticonvulsant agents, aminoglycoside antibiotics, polypeptide antibiotics, and/or metronidazole. 15. Patients required management with hypothermia during surgery. 16. Difficulty with appropriate neuromuscular monitoring. 17. Emergency surgical patients. 18. Patients with life-threatening medical condition.

Study & Design

• Study Type: Interventional
• Study Design: Not specified